aTYR PHARMA INC (LIFE) Deferred Tax Assets, Valuation Allowance USD 2013 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
aTYR PHARMA INC quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2013 to 2023.
  • aTYR PHARMA INC Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $108 M, a 13.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $108 M +$12.5 M +13.1% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $95.5 M +$11.4 M +13.5% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $84.1 M +$9.47 M +12.7% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $74.6 M +$2.94 M +4.11% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $71.7 M +$4.77 M +7.13% Dec 31, 2019 10-K 2021-03-24
Q4 2018 $66.9 M +$7.2 M +12.1% Dec 31, 2018 10-K 2020-03-26
Q4 2017 $59.7 M -$11.4 M -16.1% Dec 31, 2017 10-K 2019-03-26
Q4 2016 $71.1 M +$22.8 M +47.2% Dec 31, 2016 10-K 2018-03-20
Q4 2015 $48.3 M +$13.5 M +38.7% Dec 31, 2015 10-K 2017-03-16
Q4 2014 $34.8 M +$13.6 M +63.7% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $21.3 M Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.